NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

NCT06433752

RecruitingN/A

Sponsor: TG Therapeutics, Inc.

Conditions: Relapsing Multiple Sclerosis, Multiple Sclerosis

Interventions: No Intervention

Countries: United States, Puerto Rico

The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Confirmed Multiple Sclerosis (MS) diagnosis.
2. Participants who have not received any BRIUMVI® (ublituximab-xiiy) infusion prior to study start. Participants who have been prescribed BRIUMVI® (ublituximab-xiiy) but have not yet received their first infusion on Day 1 of 150 milligrams (mg) can be included.

Exclusion Criteria:

1. Have received any live or live-attenuated vaccines (including for varicella-zoster virus or measles) within 4 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration or any non-live vaccines within 2 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration.
2. Any active infection (e.g., active Hepatitis B virus \[HBV\])
3. Concurrent participation in any interventional MS trials, or planned concurrent treatment with other Multiple Sclerosis Disease Modifying Therapy (MS DMT) during the study period.

Locations (91)

Birmingham, Alabama, United States
Huntsville, Alabama, United States
Mobile, Alabama, United States
Gilbert, Arizona, United States
Phoenix, Arizona, United States
Scottsdale, Arizona, United States
Fresno, California, United States
Newport Beach, California, United States
Orange, California, United States
West Hollywood, California, United States
Aurora, Colorado, United States
Basalt, Colorado, United States
Colorado Springs, Colorado, United States
Denver, Colorado, United States
Fort Collins, Colorado, United States
Grand Junction, Colorado, United States
Farmington, Connecticut, United States
Hartford, Connecticut, United States
Wilmington, Delaware, United States
Washington D.C., District of Columbia, United States
Altamonte Springs, Florida, United States
Boca Raton, Florida, United States
Clearwater, Florida, United States
Maitland, Florida, United States
Miami, Florida, United States
Naples, Florida, United States
Weston, Florida, United States
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Smyrna, Georgia, United States
+ 61 more on CT.gov